Latest News about ESPR
Recent news which mentions ESPR
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Friday's Pre-Market Session
December 03, 2021
From Benzinga
68 Biggest Movers From Wednesday
November 26, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 24, 2021
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
November 24, 2021
From Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
November 24, 2021
From Benzinga
From InvestorPlace
56 Biggest Movers From Yesterday
November 24, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 23, 2021
From Benzinga
Esperion Therapeutics, inc (ESPR) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
ESPR
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 02, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
56 Biggest Movers From Yesterday
October 26, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 25, 2021
From Benzinga
35 Stocks Moving In Monday's Mid-Day Session
October 25, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
From Benzinga
44 Biggest Movers From Yesterday
October 15, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
October 14, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 24, 2021
From Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.